FPWR Blog

More reasons than ever to be optimistic of a new FDA approved treatment for PWS
More reasons than ever to be optimistic of a new FDA approved treatment for PWS
  We have more reasons than ever to be optimistic of a new FDA approved treatment for PWS in 2020. Just last week we learned of successful enrollment for the second ongoing pivotal PWS clinical trial (Soleno’s Destiny PWS study), which comes on the heels of Millendo’s Zephyr study reaching its...
Read more »
Source: FPWR Blog | Published: January 1 2020 - 10:57 AM
Fundraising for PWS — Panel [2019 CONFERENCE VIDEO]
Fundraising for PWS — Panel [2019 CONFERENCE VIDEO]
In this 45-minute video, Sarah Peden, Director of One Small Step and FPWR's Community Development Director highlights the success of the PWS community in raising funds for PWS research. Sarah and parents of children with PWS share how they've gotten involved in supporting PWS research, generating...
Read more »
Source: FPWR Blog | Published: January 1 2020 - 10:25 AM
Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Prader Willi Syndrome
Soleno Therapeutics Completes Target Enrollment in Ongoing DESTINY PWS Phase III Trial of DCCR in Prader Willi Syndrome
Soleno Therapeutics has announced that it has completed their target enrollment for their ongoing Phase 3 trial of DCCR for the treatment of PWS. Approximately 100 people with PWS have enrolled in the study. Enrollment of patients was from 27 sites in the U.S. and the UK.  No serious, unexpected...
Read more »
Source: FPWR Blog | Published: January 1 2020 - 09:24 AM